NCT05635747View on ClinicalTrials.gov

A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

Enrolling by invitationOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

September 29, 2026

Study Completion Date

September 29, 2027

Conditions
Short Bowel SyndromeMalabsorption
Interventions
DEVICE

Relizorb Enzyme Cartridge

Tube feeds run across device to digest fats.

Trial Locations (1)

02115

Boston Children's Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Alcresta Therapeutics, Inc.

INDUSTRY

lead

Boston Children's Hospital

OTHER